NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Matrisome Bio

Matrisome Bio

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://matrisomebio.com/

Last Round

Grant

Sep 2, 2025

Total Funding Raised

$1.59M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Matrisome Bio is a biotechnology company developing a therapeutic platform that uses nanobodies to target the extracellular matrix for the treatment of cancer and other chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

extracellular matrixECMdrug discoveryoncology therapeuticsfibrosis treatmentmatrisomenanobody platformtarget identificationbiotech licensingpreclinical drug candidatesundruggable targetsbiopharma partnershipdrug discovery engineprotein analysiswet-lab biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Matrisome Bio Comparables

Compare Matrisome Bio with similar companies based on industry and business-model similarity.

Matrisome Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Engitix Therapeutics
82%
Tandem Therapeutics AG
79%
Albatroz Therapeutics
78%

Matrisome Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 2, 2025

Matrisome Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 303% MoM, reaching 677.

  • Apr 1, 2026

    Monthly visitors grew 583% MoM.

Matrisome Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Matrisome Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Matrisome Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range11
Year Founded2023
Last FundingSep 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.